Skip to main content

Table 1 Clinicopathologic characteristics of the patients with HCC

From: TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A

Parameters

Total number of the patients (N = 87)

Age (years)

 ≤53

47 (54.0%)

 > 53

40 (46.0%)

Sex

 Female

8 (9.2%)

 Male

79 (90.8%)

Tumor size (cm)

 ≤4

25 (28.7%)

 > 4

62 (71.3%)

Recurrence (2 years)

 Yes

63 (72.4%)

 No

24 (27.6%)

Differentiation

 Low

39 (44.8%)

 Moderate

38 (43.7%)

 High

10 (11.5%)

Tumor number

 Single

64 (73.6%)

 Multiple

23 (26.4%)

TNM stages

 I

15 (17.2%)

 II

22 (25.3%)

 III

20 (23.0%)

 IV

30 (34.5%)

Pathologic stages

 I

6 (6.9%)

 II

34 (39.1%)

 III

40 (46.0%)

 IV

7 (8.0%)

Lung metastasis

 Yes

 No

16 (18.4%)

71 (81.6%)

HBsAg

 Negative

7 (8.0%)

 Positive

80 (92.0%)

HBV infection

 Absent

7 (8.0%)

 Present

80 (92.0%)

  1. HBsAg: hepatitis B surface antigen; HBV: hepatitis B virus